Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schwabe, Stefan
127  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

A Phase III, Randomized, Double-Blind, Placebo-Controlled T..:

Nasser, Azmi ; Hull, Joseph T ; Chaturvedi, Soumya A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328182/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

Data Publication: What is the speed limit of martensitic tr..:

Schwabe, Stefan ; Lünser, Klara ; Schmidt, Daniel...
url:http://arxiv.org/abs/2202.12581.  , 2022
Link: https://rodare.hzdr.de/r..
 
?
3

Farming the Uncanny Valley:

Schwabe, Stefan ; Hülsen, Jannis ; Trübswetter, Angelika (Dr.)...
https://opus4.kobv.de/opus4-udk/frontdoor/index/index/docId/1787.  , 2022
Link: https://opus4.kobv.de/op..
 
?
4

What is the speed limit of martensitic transformations?:

Schwabe, Stefan ; Luenser, Klara ; Schmidt, Daniel...
info:eu-repo/semantics/altIdentifier/doi/10.1080/14686996.2022.2128870.  , 2022
Link: https://bib-pubdb1.desy...
 
?
5

What is the speed limit of martensitic transformations?:

Schwabe, Stefan ; Lünser, Klara ; Schmidt, Daniel...
ISSN:1468-6996.  , 2022
Link: https://oa.tib.eu/renate..
 
?
6

What is the speed limit of martensitic transformations?:

Schwabe, Stefan ; Lünser, Klara ; Schmidt, Daniel...
http://arxiv.org/abs/2202.12581.  , 2022
Link: http://arxiv.org/abs/220..
 
?
7

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazin..:

Nasser, Azmi ; Liranso, Tesfaye ; Adewole, Toyin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244935/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812..:

Wang, Zhao ; Kosheleff, Alisa R ; Adeojo, Lilian W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597116/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Impact of a High-Fat Meal and Sprinkled Administration on t..:

Wang, Zhao ; Kosheleff, Alisa R ; Adeojo, Lilian W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752548/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Viloxazine in the Management of CNS Disorders: A Historical..:

Findling, Robert L ; Candler, Shawn A ; Nasser, Azmi F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219567/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Population Pharmacokinetics of Viloxazine Extended‐Release ..:

Nasser, Azmi ; Gomeni, Roberto ; Wang, Zhao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291887/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Predicted Efficacy of Once-Daily Extended-Release Oxcarbaze..:

Faison, Shamia ; Gomeni, Roberto ; Mendes, Shannon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520464/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Pharmacokinetics of Coadministered Viloxazine Extended-Rele..:

Faison, Shamia L ; Fry, Nicholas ; Adewole, Toyin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886742/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

New Insights into the Mechanism of Action of Viloxazine: Se..:

Yu, Chungping ; Garcia-Olivares, Jennie ; Candler, Shawn..
info:eu-repo/semantics/altIdentifier/doi/10.2147/JEP.S256586.  , 2020
Link: https://www.dovepress.co..
 
?
15

Building Hierarchical Martensite:

Schwabe, Stefan ; Niemann, Robert ; Backen, Anja...
ISSN:1616-301X.  , 2020
Link: https://oa.tib.eu/renate..
 
1-15